Search for: "In re Eon Labs" Results 1 - 20 of 23
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jul 2007, 8:10 pm
  KV Pharmaceutical, Andrx, and Eon Labs have all filed ANDAs for generic Toprol-XL and are defendants in the litigation. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Watson Labs raises a core substantive patent issue – does the on sale bar apply to secret sales? [read post]
1 Sep 2010, 4:46 pm by Dennis Crouch
Eon Labs, Inc. and Elan Pharmaceuticals, Inc. at http://www.patentlyo.com/patent/2010/08/ignoring-non-patentable-elements-while-judging-novelty.html Hyatt v. [read post]
20 May 2011, 3:06 pm
Eon Labs, Inc., 616 F.3d 1267, 1282 (Fed. [read post]
26 Sep 2007, 1:04 pm
Purepac Pharma, Faulding, Watson Pharma, Danbury Pharma, Teva, Zenith Labs, Ivax, Apotex, Torpharm and Eon Labs) United States Court of Appeals for the Federal Circuit (06-1572). [read post]
18 May 2018, 8:54 am by Dennis Crouch
Eon Labs and In re Kao, the Federal Circuit had already extended the printed matter doctrine to encompass the conveyance of information in non-printed forms, such as verbal speech or sign language. [read post]
13 Feb 2009, 8:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]